Article
Age-Specific Differences in Omalizumab-Related Adverse Drug Reaction Signals between Children and Adults: An Analysis Based on the FAERS Database
2026-03-05
Abstract excerpt
<h4>Objective: </h4> :To analyze age-specific differences in post-marketing adverse drug reaction (ADR) signals of omalizumab between children (<18 years) and adults (≥18 years) using FAERS data, to inform optimized medication safety monitoring strategies. Methods:Omalizumab-related ADR reports (2003Q1–2025Q3) were extracted from FAERS and stratified by age. ADRs were coded with MedDRA. Signals were mined using fo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 04b44eab-deaf-5258-b692-bec136f1a605
- DOI
- 10.22541/au.177270317.73494041/v1
